Skip to content

Peroral Endoscopic Remyotomy for Failed Heller Myotomy

Peroral Endoscopic Remyotomy for Failed Heller Myotomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01637311
Enrollment
20
Registered
2012-07-11
Start date
2010-01-31
Completion date
2014-12-31
Last updated
2012-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Keywords

Peroral endoscopic myotomy, Heller myotomy, persistent/recurrent achalasia.

Brief summary

Achalasia is a rare esophageal motility disorder, which is characterized clinically by symptoms of dysphagia, regurgitation, weight loss and chest pain. With respect to long-term efficacy, Heller myotomy (HM) using an open or a laparoscopic approach has gained wide acceptance as the procedure of choice for the management of patients with primary achalasia in recent years. Although good or excellent long-term symptomatic response rates can be achieved in more than 90% of patients undergoing HM, recurrence or persistence of symptoms occurs in approximately 20%. Controversy exists regarding the therapy of patients with failed success after HM. Peroral endoscopic myotomy (POEM) has recently been described as a new minimally invasive endoscopic myotomy technique intending a permanent cure from primary achalasia. Our purpose was to evaluate the efficacy and the feasibility of POEM for patients with failed HM.

Detailed description

1. Patients were eligible for enrollment in the study if they were age greater than 18 years and had recurrence/persistence of symptoms after primary HM with an Eckardt symptom score ≥ 4. The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy (EGD)). Exclusion criteria were severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk, pseudoachalasia, and megaesophagus (diameter of \> 7 cm). 2. All patients were scheduled for a follow-up visit at 1 month after POEM for EGD and manometry. Symptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires. 3. The primary outcome of the study was therapeutic success (a reduction in the Eckardt score to ≤3) at the follow-up assessment. The secondary outcomes included procedure-related adverse events, LES pressure on manometry pre- and post POEM, reflux symptoms and medication use before and after POEM, and procedure-related parameters such as procedure time, hospital stay, and myotomy length.

Interventions

PROCEDUREPOEM

Peroral endoscopic myotomy (POEM) has recently been described as a new minimally invasive endoscopic myotomy technique intending a permanent cure from primary achalasia.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 years * Recurrence/persistence of symptoms after primary HM with an Eckardt symptom score ≥ 4 * The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy)

Exclusion criteria

* Severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk * Pseudoachalasia * megaesophagus (diameter of \> 7 cm)

Design outcomes

Primary

MeasureTime frame
Therapeutic success (a reduction in the Eckardt score to ≤3)Symptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires.

Secondary

MeasureTime frame
Procedure-related adverse eventsAll patients were scheduled for a follow-up visit at 1 month after POEM for EGD.
Lower esophageal sphincter (LES) pressure on manometryAll patients were scheduled for a follow-up visit at 1 month after POEM for EGD and manometry
Reflux symptoms and medication use before and after POEMSymptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires.

Countries

China

Contacts

Primary ContactPing-Hong Zhou, MD,PhD
zhou1968@yahoo.cn(+86)-21-64041990

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026